BioLogic Equity Starts Seattle Genetics (SGEN) at Sell
Tweet Send to a FriendGet Alerts SGEN Hot Sheet
Price: $35.35 +0.57%
Rating Summary:
5 Buy, 5 Hold, 10 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 29
Rating Summary:
5 Buy, 5 Hold, 10 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 29
Trade SGEN Now!
BioLogic Equity Research initiated coverage on Seattle Genetics (NASDAQ: SGEN) with a Sell rating today.
The stock last traded at $14.73, down 1.3% from yesterday's closing price.
For more ratings news on Seattle Genetics click here and for the rating history of Seattle Genetics click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The stock last traded at $14.73, down 1.3% from yesterday's closing price.
For more ratings news on Seattle Genetics click here and for the rating history of Seattle Genetics click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Topeka Capital Starts InvenSense (INVN) at Buy
- Topeka Capital Starts CEVA Inc. (CEVA) at Buy
- Maxim Group Assumes Trina Solar (TSL) at Hold
Create E-mail Alert Related Categories
New Coverage
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
